share_log

ゼリア新薬工業:Tillotts PharmaとTVM Capital Life Scienceが潰瘍性大腸炎に対する経口抗体療法開発を目的としてMage Biologicsを設立することを発表

Zeria Pharmaceutical: Tillotts Pharma and TVM Capital Life Science announce they will establish Mage Biologics for the purpose of developing oral antibody therapy against ulcerative colitis

JPX ·  Jul 28, 2023 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more